Approval · Notice of Compliance 33090 · 2024
ACYCLOVIR: Notice of Compliance 33090
Issued April 19, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33090
- Date
- April 19, 2024
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug substance manufacturer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR | Not yet assigned | — |